Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-01 Sale |
2024-10-02 4:31 pm |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,000 | $10.11 | $101,052 | 11,286 (Direct) |
View |
| 2024-09-03 Sale |
2024-09-04 8:20 pm |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,000 | $11.56 | $115,588 | 21,286 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 6:39 pm |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,100 | $13.51 | $136,454 | 32,686 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 6:39 pm |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer |
100 | $15 | $1,500 | 170,037 (Direct) |
View |
| 2024-07-29 Sale |
2024-07-30 5:01 pm |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
11,000 | $15.04 | $165,495 | 12,786 (Direct) |
View |
| 2024-07-29 Sale |
2024-07-30 5:01 pm |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer |
9,648 | $15.04 | $145,106 | 170,137 (Direct) |
View |
| 2024-07-24 Sale |
2024-07-26 5:00 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. Director |
27,590 | $13.88 | $382,934 | 526,112 (Direct) |
View |
| 2024-07-16 Sale |
2024-07-18 5:05 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. Director |
2,410 | $13.77 | $33,192 | 568,133 (Direct) |
View |
| 2024-07-01 Sale |
2024-07-03 07:55 am |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,000 | $11.27 | $112,691 | 41,286 (Direct) |
View |
| 2024-05-14 Sale |
2024-05-16 5:06 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $15.81 | $237,222 | 489,389 (Direct) |
View |
| 2024-04-15 Sale |
2024-04-17 5:05 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $18.19 | $272,871 | 504,389 (Direct) |
View |
| 2024-03-14 Sale |
2024-03-18 5:03 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $21.86 | $327,942 | 519,389 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-07 6:05 pm |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
12,878 | $28.36 | $365,220 | 138,469 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-01 Tax Withholding |
2025-04-04 5:17 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer |
4,700 | $8.07 | 156,110 (Direct) |
View |
| 2025-02-01 Tax Withholding |
2025-04-04 5:17 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
5,263 | $8.07 | 210,717 (Direct) |
View |
| 2025-02-01 Tax Withholding |
2025-04-04 5:16 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
5,452 | $8.07 | 226,348 (Direct) |
View |
| 2025-03-27 Exercise |
2025-03-31 5:05 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. Director |
30,752 | $0 | 495,705 (Direct) |
View |
| 2025-03-27 Exercise |
2025-03-31 5:05 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. Director |
30,752 | $3.76 | 495,705 (Direct) |
View |
Ownership |
2025-03-24 7:02 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Malzahn Craig Chief Technology Officer |
0 | $0 | 133,249 (Direct) |
View |
| 2025-01-02 Option Award(A) |
2025-01-14 5:19 pm |
N/A 2035-01-02 |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer |
478,606 | $0 | 478,606 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:59 pm |
N/A 2035-01-02 |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
167,991 | $0 | 319,678 (Direct) |
View |
| 2025-01-02 Tax Withholding |
2025-01-06 4:59 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
13,891 | $7.73 | 319,678 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:59 pm |
N/A 2035-01-02 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
155,068 | $0 | 327,521 (Direct) |
View |
| 2025-01-02 Tax Withholding |
2025-01-06 4:59 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
12,630 | $7.73 | 327,521 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:59 pm |
N/A 2035-01-02 |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer |
575,518 | $0 | 733,638 (Direct) |
View |
| 2025-01-02 Tax Withholding |
2025-01-06 4:59 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer |
11,917 | $7.73 | 733,638 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:59 pm |
N/A 2035-01-02 |
REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer |
62,547 | $0 | 62,547 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:59 pm |
N/A 2035-01-02 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer |
223,350 | $0 | 384,160 (Direct) |
View |
| 2025-01-02 Tax Withholding |
2025-01-06 4:59 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer |
11,395 | $7.73 | 384,160 (Direct) |
View |
| 2024-10-01 Exercise |
2024-10-02 4:31 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,000 | $0 | 11,286 (Direct) |
View |
| 2024-10-01 Exercise |
2024-10-02 4:31 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,000 | $3.76 | 11,286 (Direct) |
View |
| 2024-09-16 Option Award |
2024-09-18 5:04 pm |
N/A 2034-09-16 |
REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer |
348,231 | $0 | 348,231 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-04 8:20 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,000 | $0 | 21,286 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-04 8:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,000 | $3.76 | 21,286 (Direct) |
View |
| 2024-08-08 Exercise |
2024-08-12 4:58 pm |
N/A 2024-09-24 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. Director |
36,316 | $0 | 444,351 (Direct) |
View |
| 2024-08-08 Exercise |
2024-08-12 4:58 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. Director |
36,316 | $0.85 | 444,351 (Direct) |
View |
| 2024-08-01 Option Award |
2024-08-05 6:41 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
58,386 | $0 | 165,578 (Direct) |
View |
| 2024-08-01 Option Award |
2024-08-05 6:39 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer |
56,446 | $0 | 172,205 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-05 6:39 pm |
N/A 2026-06-01 |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,100 | $0 | 32,686 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-05 6:39 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
100 | $12.74 | 32,686 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-05 6:39 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,000 | $3.76 | 32,686 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-05 6:38 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
1,363 | $9.945 | 185,083 (Direct) |
View |
| 2024-08-01 Option Award |
2024-08-05 6:38 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
58,867 | $0 | 185,083 (Direct) |
View |
| 2024-07-29 Exercise |
2024-07-30 5:01 pm |
N/A 2026-06-01 |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
11,000 | $0 | 12,786 (Direct) |
View |
| 2024-07-29 Exercise |
2024-07-30 5:01 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
11,000 | $12.74 | 12,786 (Direct) |
View |
| 2024-07-24 Exercise |
2024-07-26 5:00 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. Director |
27,590 | $0 | 526,112 (Direct) |
View |
| 2024-07-24 Exercise |
2024-07-26 5:00 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. Director |
27,590 | $3.76 | 526,112 (Direct) |
View |
| 2024-07-16 Exercise |
2024-07-18 5:05 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. Director |
2,410 | $0 | 568,133 (Direct) |
View |
| 2024-07-16 Exercise |
2024-07-18 5:05 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. Director |
2,410 | $3.76 | 568,133 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 07:56 am |
N/A 2034-07-01 |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer |
328,647 | $0 | 451,974 (Direct) |
View |
| 2024-07-01 Exercise |
2024-07-03 07:55 am |
N/A 2025-05-18 |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,000 | $0 | 41,286 (Direct) |
View |
| 2024-07-01 Exercise |
2024-07-03 07:55 am |
N/A N/A |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
10,000 | $3.76 | 41,286 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 4:43 pm |
N/A 2034-05-31 |
REGENXBIO Inc. | RGNX | Zachary Jennifer Director |
29,244 | $0 | 38,750 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 4:43 pm |
N/A 2034-05-31 |
REGENXBIO Inc. | RGNX | MIGAUSKY GEORGE V Director |
29,244 | $0 | 35,740 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 4:42 pm |
N/A 2034-05-31 |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
29,244 | $0 | 35,740 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 4:42 pm |
N/A 2034-05-31 |
REGENXBIO Inc. | RGNX | Glucksmann Alexandra Director |
29,244 | $0 | 35,740 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 4:41 pm |
N/A 2034-05-31 |
REGENXBIO Inc. | RGNX | Bennett Jean Director |
29,244 | $0 | 35,740 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 4:41 pm |
N/A 2034-05-31 |
REGENXBIO Inc. | RGNX | Fox Allan M. Director |
29,244 | $0 | 2,918,206 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 4:40 pm |
N/A 2034-05-31 |
REGENXBIO Inc. | RGNX | Tasse Daniel Director |
29,244 | $0 | 35,740 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 4:39 pm |
N/A 2034-05-31 |
REGENXBIO Inc. | RGNX | STUMP DAVID C Director |
29,244 | $0 | 35,740 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-16 5:06 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $0 | 489,389 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-16 5:06 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $3.76 | 489,389 (Direct) |
View |
| 2024-04-15 Exercise |
2024-04-17 5:05 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $0 | 504,389 (Direct) |
View |
| 2024-04-15 Exercise |
2024-04-17 5:05 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $3.76 | 504,389 (Direct) |
View |
| 2024-03-19 Exercise |
2024-03-21 5:20 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
20,041 | $0 | 246,534 (Direct) |
View |
| 2024-03-19 Exercise |
2024-03-21 5:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
20,041 | $3.76 | 246,534 (Direct) |
View |
| 2024-03-14 Exercise |
2024-03-18 5:03 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $0 | 519,389 (Direct) |
View |
| 2024-03-14 Exercise |
2024-03-18 5:03 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $3.76 | 519,389 (Direct) |
View |
| 2024-03-05 Exercise |
2024-03-07 6:05 pm |
N/A 2033-01-03 |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
12,878 | $0 | 138,469 (Direct) |
View |
| 2024-03-05 Exercise |
2024-03-07 6:05 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
12,878 | $22.25 | 138,469 (Direct) |
View |